MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences
- PMID: 33398421
- PMCID: PMC8213603
- DOI: 10.1007/s00330-020-07545-7
MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences
Abstract
Objectives: To assess the multiparametric MRI (mpMRI) appearances of normal peripheral zone (PZ) across age groups in a biopsy-naïve population, where prostate cancer (PCa) was subsequently excluded, and propose a scoring system for background PZ changes.
Methods: This retrospective study included 175 consecutive biopsy-naïve patients (40-74 years) referred with a suspicion of PCa, but with subsequent negative investigations. Patients were grouped by age into categories ≤ 54, 55-59, 60-64, and ≥ 65 years. MpMRI sequences (T2-weighted imaging [T2WI], diffusion-weighted imaging [DWI]/apparent diffusion coefficient [ADC], and dynamic contrast-enhanced imaging [DCE]) were independently evaluated by two uro-radiologists on a proposed 4-point grading scale for background change on each sequence, wherein score 1 mirrored PIRADS-1 change and score 4 represented diffuse background change. Peripheral zone T2WI signal intensity and ADC values were also analyzed for trends relating to age.
Results: There was a negative correlation between age and assigned background PZ scores for each mpMRI sequence: T2WI: r = - 0.52, DWI: r = - 0.49, DCE: r = - 0.45, p < 0.001. Patients aged ≤ 54 years had mean scores of 3.0 (T2WI), 2.7 (DWI), and 3.1 (DCE), whilst patients ≥ 65 years had significantly lower mean scores of 1.7, 1.4, and 1.9, respectively. There was moderate inter-reader agreement for all scores (range κ = 0.43-0.58). Statistically significant positive correlations were found for age versus normalized T2WI signal intensity (r = 0.2, p = 0.009) and age versus ADC values (r = 0.33, p = 0.001).
Conclusion: The normal PZ in younger patients (≤ 54 years) demonstrates significantly lower T2WI signal intensity, lower ADC values, and diffuse enhancement on DCE, which may hinder diagnostic interpretation in these patients. The proposed standardized PZ background scoring system may help convey the potential for diagnostic uncertainty to clinicians.
Key points: • Significant, positive correlations were found between increasing age and higher normalized T2-weighted signal intensity and mean ADC values of the prostatic peripheral zone. • Younger men exhibit lower T2-weighted imaging signal intensity, lower ADC values, and diffuse enhancement on dynamic contrast-enhanced imaging, which may hinder MRI interpretation. • A scoring system is proposed which aims towards a standardized assessment of the normal background PZ. This may help convey the potential for diagnostic uncertainty to clinicians.
Keywords: Aging; Anatomy; Multiparametric MRI; Normal anatomy; Prostate cancer.
Conflict of interest statement
The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Figures






Similar articles
-
Prostate heterogeneity correlates with clinical features on multiparametric MRI.Abdom Radiol (NY). 2021 Nov;46(11):5369-5376. doi: 10.1007/s00261-021-03221-6. Epub 2021 Jul 22. Abdom Radiol (NY). 2021. PMID: 34292363
-
Correlation of multiparametric MRI with histopathological grade of peripheral zone prostate carcinoma.J Cancer Res Ther. 2023 Jan 1;19(Suppl 2):S569-S576. doi: 10.4103/jcrt.jcrt_280_22. Epub 2023 Apr 28. J Cancer Res Ther. 2023. PMID: 38384020
-
MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy.Eur Radiol. 2014 Oct;24(10):2582-9. doi: 10.1007/s00330-014-3276-9. Epub 2014 Jun 28. Eur Radiol. 2014. PMID: 24972954
-
Multiparametric MRI in detection and staging of prostate cancer.Dan Med J. 2017 Feb;64(2):B5327. Dan Med J. 2017. PMID: 28157066 Review.
-
Multiparametric MRI in the Diagnosis of Prostate Cancer: Physical Foundations, Limitations, and Prospective Advances of Diffusion-Weighted MRI.Rofo. 2021 Apr;193(4):399-409. doi: 10.1055/a-1276-1773. Epub 2020 Dec 10. Rofo. 2021. PMID: 33302312 Review. English.
Cited by
-
Pseudo-T2 mapping for normalization of T2-weighted prostate MRI.MAGMA. 2022 Aug;35(4):573-585. doi: 10.1007/s10334-022-01003-9. Epub 2022 Feb 12. MAGMA. 2022. PMID: 35150363 Free PMC article.
-
Association of Oxidative Stress with Neurological Disorders.Curr Neuropharmacol. 2022;20(6):1046-1072. doi: 10.2174/1570159X19666211111141246. Curr Neuropharmacol. 2022. PMID: 34781871 Free PMC article.
-
The role of quantitative MRI-based prostate zonal parameters in predicting clinically significant prostate cancer A U.S. cohort.Can Urol Assoc J. 2023 Jul;17(7):E182-E188. doi: 10.5489/cuaj.8195. Can Urol Assoc J. 2023. PMID: 37068148 Free PMC article.
-
Risk of Clinically Significant Prostate Cancer after a Nonsuspicious Prostate MRI-A Comparison with the General Population.Cancer Epidemiol Biomarkers Prev. 2024 May 1;33(5):749-756. doi: 10.1158/1055-9965.EPI-23-1208. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 38270536 Free PMC article.
-
Reproducibility of magnetic resonance fingerprinting-based T1 mapping of the healthy prostate at 1.5 and 3.0 T: A proof-of-concept study.PLoS One. 2021 Jan 29;16(1):e0245970. doi: 10.1371/journal.pone.0245970. eCollection 2021. PLoS One. 2021. PMID: 33513165 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I (2018) Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 394–424. 10.3322/caac.21492 - PubMed
-
- US Preventive Services Task Force (2018) Final Recommendation Statement: Prostate Cancer: Screening. US Preventive Services Task Force, Rockville, MD, USA. Available via https://www.uspreventiveservicestaskforce.org/Page/Document/Recommendati.... Accessed 17 Jun 2020
-
- Mottet N, van den Bergh RCN, Briers E, et al (2020) EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 10.1016/j.eururo.2020.09.042 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical